HIGHLIGHTS
- who: Hao Jin from the Sun Yat-sen University Cancer Center (SYSUCC), China have published the research work: Risk factors from Framingham risk score for anthracyclines cardiotoxicity in breast cancer: A systematic review and meta-analysis, in the Journal: (JOURNAL)
- what: Anthracyclines are widely used in the treatment of breast cancer , but anthracycline-induced cardiotoxicity is the main reason for their limited use in the clinical setting. The authors examined the effect of risk factors in the FRS on anthracycline-induced cardiotoxicity to determine the importance of cardiovascular risk factor assessment in anthracycline treatment of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.